Manuel Romero‐Gómez

56.4k total citations · 8 hit papers
375 papers, 14.7k citations indexed

About

Manuel Romero‐Gómez is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Manuel Romero‐Gómez has authored 375 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 266 papers in Epidemiology, 210 papers in Hepatology and 75 papers in Surgery. Recurrent topics in Manuel Romero‐Gómez's work include Liver Disease Diagnosis and Treatment (242 papers), Hepatitis C virus research (103 papers) and Liver Disease and Transplantation (97 papers). Manuel Romero‐Gómez is often cited by papers focused on Liver Disease Diagnosis and Treatment (242 papers), Hepatitis C virus research (103 papers) and Liver Disease and Transplantation (97 papers). Manuel Romero‐Gómez collaborates with scholars based in Spain, United States and United Kingdom. Manuel Romero‐Gómez's co-authors include Shira Zelber‐Sagi, Michael I. Trenell, M. Diago, Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Javier Ampuero, Licet Gonzalez‐Fabian, Scott L. Friedman, Bienvenido Gra‐Oramas and Raúl J. Andrade and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Manuel Romero‐Gómez

361 papers receiving 14.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

2015 1.7k citations Scott L. Friedman, M. Diago et al. Gastroenterology profile →
Treatment of NAFLD with diet, physical activity and exercise

2017 948 citations Manuel Romero‐Gómez, Shira Zelber‐Sagi et al. Journal of Hepatology profile →
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

2018 603 citations Zobair M. Younossi, Maria Stepanova et al. profile →
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

2016 581 citations Salvatore Petta, Manuel Romero‐Gómez et al. profile →
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

2018 574 citations Vincent Wai‐Sun Wong, Mohammed Eslam et al. Gastroenterology profile →
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

2005 556 citations Manuel Romero‐Gómez, Raúl J. Andrade et al. Gastroenterology profile →
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy

2022 207 citations Sara Montagnese, Manuel Romero‐Gómez et al. Journal of Hepatology profile →
Hepatic encephalopathy

2022 109 citations Dieter Häussinger, Radha K. Dhiman et al. Nature Reviews Disease Primers profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Manuel Romero‐Gómez	11.1k	8.0k	3.0k	2.5k	1.5k	375	14.7k
Emmanuel Tsochatzis	12.1k 1.1×	9.4k 1.2×	2.5k 0.8×	3.4k 1.3×	1.4k 0.9×	308	15.8k
Ali Canbay	9.0k 0.8×	5.1k 0.6×	2.3k 0.8×	2.9k 1.2×	3.8k 2.4×	387	14.7k
Stephen H. Caldwell	14.5k 1.3×	10.3k 1.3×	4.2k 1.4×	4.3k 1.7×	1.9k 1.2×	259	19.1k
Elizabeth E. Powell	9.3k 0.8×	6.6k 0.8×	2.5k 0.8×	1.9k 0.8×	1.8k 1.2×	213	13.8k
Richard K. Sterling	15.8k 1.4×	13.7k 1.7×	2.9k 1.0×	4.4k 1.7×	2.1k 1.4×	326	20.6k
Velimir A. Luketic	10.5k 0.9×	9.1k 1.1×	2.3k 0.8×	4.7k 1.8×	1.5k 1.0×	176	14.2k
Philippe Mathurin	14.1k 1.3×	9.7k 1.2×	3.1k 1.0×	2.7k 1.1×	1.9k 1.2×	349	19.0k
Marco Arrese	6.8k 0.6×	2.9k 0.4×	2.4k 0.8×	2.7k 1.1×	2.2k 1.4×	243	11.0k
Jörn M. Schattenberg	6.7k 0.6×	3.4k 0.4×	2.5k 0.8×	1.5k 0.6×	1.6k 1.0×	332	9.2k
Flemming Bendtsen	8.0k 0.7×	6.5k 0.8×	1.3k 0.4×	4.1k 1.6×	1.2k 0.8×	340	12.1k

Countries citing papers authored by Manuel Romero‐Gómez

Since Specialization

Citations

This map shows the geographic impact of Manuel Romero‐Gómez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Romero‐Gómez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Romero‐Gómez more than expected).

Fields of papers citing papers by Manuel Romero‐Gómez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Romero‐Gómez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Romero‐Gómez. The network helps show where Manuel Romero‐Gómez may publish in the future.

Co-authorship network of co-authors of Manuel Romero‐Gómez

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Romero‐Gómez. A scholar is included among the top collaborators of Manuel Romero‐Gómez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Romero‐Gómez. Manuel Romero‐Gómez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alqahtani, Saleh A., et al.. (2025). Energy metabolism: An emerging therapeutic frontier in liver fibrosis. Annals of Hepatology. 30(1). 101896–101896. 1 indexed citations

Zábal, José Miguel Rosales, Manuel Rodríguez‐Perálvarez, Alberto García-García, et al.. (2025). Prognostic implications of recompensation of decompensated cirrhosis after SVR in patients with hepatitis C. Journal of Hepatology. 83(3). 652–661. 1 indexed citations

Rodríguez, Agustín Martín, María Ángeles Pérez-San-Gregorio, Luke Vale, et al.. (2024). Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom. PLoS ONE. 19(5). e0300362–e0300362. 2 indexed citations

Múñoz‐Hernández, Rocío, Antonio Gil‐Gómez, R. Aller, et al.. (2023). Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD. Liver International. 43(9). 1909–1919. 5 indexed citations

Ballester, María Pilar, Thomas H. Tranah, Lorenz Balcar, et al.. (2023). Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis. Journal of Hepatology. 79(4). 967–976. 25 indexed citations

Romero‐Gómez, Manuel, et al.. (2023). Improved health‐related quality of life with semaglutide in people with non‐alcoholic steatohepatitis: A randomised trial. Alimentary Pharmacology & Therapeutics. 58(4). 395–403. 13 indexed citations

Ratziu, Vlad, Marcus Hompesch, Janani Iyer, et al.. (2023). Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions. Journal of Hepatology. 80(2). 335–351. 47 indexed citations

Silvestri, Alessandra, Antonio Gil‐Gómez, Daniele Braga, et al.. (2023). Biomimetic superabsorbent hydrogel acts as a gut protective dynamic exoskeleton improving metabolic parameters and expanding A. muciniphila. Cell Reports Medicine. 4(10). 101235–101235. 16 indexed citations

Lewińska, Monika, et al.. (2023). Serum lipidome unravels a diagnostic potential in bile acid diarrhoea. Gut. 72(9). 1698–1708. 11 indexed citations

10.

Häussinger, Dieter, Radha K. Dhiman, Vicente Felipo, et al.. (2022). Hepatic encephalopathy. Nature Reviews Disease Primers. 8(1). 43–43. 109 indexed citations breakdown →

11.

Lazarus, Jeffrey V., Henry E. Mark, Massimo Colombo, et al.. (2021). A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach. Alimentary Pharmacology & Therapeutics. 55(2). 234–243. 8 indexed citations

12.

Hernández–Gea, Virginia, Genís Campreciós, Valeria Pérez‐Campuzano, et al.. (2021). Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease. Journal of Hepatology. 75(4). 924–934. 18 indexed citations

13.

Younossi, Zobair M., Vincent Wai‐Sun Wong, Quentin M. Anstee, et al.. (2020). Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes. Hepatology Communications. 4(11). 1637–1650. 42 indexed citations

14.

Liu, Feng, George Boon‐Bee Goh, Dina Tiniakos, et al.. (2019). qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis. Hepatology. 71(6). 1953–1966. 82 indexed citations

15.

Ampuero, Javier, et al.. (2018). New therapeutic perspectives in non-alcoholic steatohepatitis. Gastroenterología y Hepatología (English Edition). 41(2). 128–142. 1 indexed citations

16.

Ampuero, Javier, Pablo Bellot, Rocío Gallego‐Durán, et al.. (2016). Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver International. 37(2). 212–223. 30 indexed citations

17.

Giannini, Edoardo G., Nezam H. Afdhal, Samuel H. Sigal, et al.. (2015). Non‐cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy. Journal of Gastroenterology and Hepatology. 30(8). 1301–1308. 4 indexed citations

18.

Ampuero, Javier, Manuel Romero‐Gómez, & K. Rajender Reddy. (2014). Review article: HCV genotype 3 – the new treatment challenge. Alimentary Pharmacology & Therapeutics. 39(7). 686–698. 81 indexed citations

19.

Romero‐Gómez, Manuel, Ramón Planas, Javier Ampuero, et al.. (2013). Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 37(11). 1065–1073. 6 indexed citations

20.

Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact